Medtronic (MDT) Net Cash Flow Growth (1y) (2015 - 2026)

Medtronic (MDT) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 183.90 Bn 176.61 Bn 6.27 Bn -53.07%
2 Stryker 128.85 Bn 125.97 Bn 3.81 Bn 17.60%
3 Medtronic 108.77 Bn 99.55 Bn 6.41 Bn 10.50%
4 Boston Scientific 68.39 Bn 66.93 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 48.50 Bn 44.83 Bn 1.29 Bn -564.44%
6 GE HealthCare Technologies 28.36 Bn 26.08 Bn 1.98 Bn -394.13%
7 Dexcom 28.36 Bn 27.24 Bn 750.30 Mn -31.84%
8 Smith & Nephew 26.92 Bn 26.35 Bn - -
9 Koninklijke Philips 25.48 Bn 22.35 Bn 2.07 Bn 76.43%
10 Steris 21.57 Bn 21.13 Bn 697.10 Mn 57.36%

Historic Data

Download Data
DateValue
Apr 24, 2026 10.50%
Jan 23, 2026 -562.50%
Oct 24, 2025 -39.24%
Jul 25, 2025 -25,200.00%
Apr 25, 2025 350.00%
Jan 24, 2025 -108.99%
Oct 25, 2024 -46.26%
Jul 26, 2024 97.58%
Apr 26, 2024 90.43%
Jan 26, 2024 131.52%
Oct 27, 2023 -94.73%
Jul 28, 2023 88.64%
Apr 28, 2023 -866.49%
Jan 27, 2023 -237.95%
Oct 28, 2022 3,036.84%
Jul 29, 2022 -165.45%
Apr 29, 2022 125.87%
Jan 28, 2022 143.39%
Oct 29, 2021 25.20%
Jul 30, 2021 -124.37%